End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.2 EUR | +0.29% |
|
-0.59% | -10.87% |
Jul. 08 | Sector Update: Financial Stocks Advance Premarket Monday | MT |
Jul. 08 | Sector Update: Financial | MT |
Strengths
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- One of the major weak points of the company is its financial situation.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-10.87% | 17.13B | - | ||
-7.66% | 178B | C+ | ||
-6.68% | 98.53B | C | ||
-9.17% | 65.18B | A | ||
-10.68% | 44.13B | B- | ||
+8.27% | 44.05B | B- | ||
+13.76% | 42.51B | B+ | ||
+7.84% | 28.41B | B | ||
+21.35% | 25.31B | A- | ||
-9.51% | 23.31B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BAX Stock
- 4BAX Stock
- Ratings Baxter International Inc.